OPKO Health
OPK
NZ$2.14
Share price
-3.01%
Change (1 day)
5.30%
Change (1 year)
Categories
OPKO Health (OPK) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : NZ$1.35 Billion
According to OPKO Health 's latest financial reports the company's total liabilities are NZ$1.35 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
OPKO Health - Total liabilities on balance sheet (from 2001 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | NZ$1.48 B | 50.37% |
| 2023-12-31 | NZ$0.98 B | 3.19% |
| 2022-12-31 | NZ$0.95 B | -8.82% |
| 2021-12-31 | NZ$1.04 B | -5.82% |
| 2020-12-31 | NZ$1.11 B | 7.72% |
| 2019-12-31 | NZ$1.03 B | 4.84% |
| 2018-12-31 | NZ$0.98 B | -6.4% |
| 2017-12-31 | NZ$1.05 B | 7.87% |
| 2016-12-31 | NZ$0.97 B | -18.63% |
| 2015-12-31 | NZ$1.19 B | 117.18% |
| 2014-12-31 | NZ$0.55 B | -12.64% |
| 2013-12-31 | NZ$0.63 B | 499.76% |
| 2012-12-31 | NZ$0.10 B | 85.69% |
| 2011-12-31 | NZ$56.66 M | -20.22% |
| 2010-12-31 | NZ$71.02 M | -7.6% |
| 2009-12-31 | NZ$76.86 M | 108.4% |
| 2008-12-31 | NZ$36.88 M | 24.01% |
| 2007-12-31 | NZ$29.74 M | 21957.91% |
| 2006-12-31 | NZ$0.13 M | -66.73% |
| 2005-12-31 | NZ$0.4 M | 20.49% |
| 2004-12-31 | NZ$0.33 M | -78.94% |
| 2003-12-31 | NZ$1.59 M | -42.01% |
| 2002-12-31 | NZ$2.75 M | -23.98% |
| 2001-12-31 | NZ$3.62 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | NZ$192.12 B | 14,050.50% | 🇺🇸 USA |
 Abbott Laboratories ABT | NZ$53.83 B | 3,865.40% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | NZ$13.56 B | 898.89% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | NZ$53.44 B | 3,836.26% | 🇮🇱 Israel |
 Alnylam Pharmaceuticals
ALNY | NZ$6.81 B | 401.84% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | NZ$124.65 B | 9,081.13% | 🇺🇸 USA |
 LabCorp LH | NZ$15.43 B | 1,036.59% | 🇺🇸 USA |
 Ardelyx ARDX | NZ$0.43 B | -67.61% | 🇺🇸 USA |